Key result
Cancer therapies are associated with acute and chronic cardiovascular toxicities that are poorly understood mechanistically, highlighting the need for novel cardio-oncology research strategies.
Why the study?
Cardiovascular toxicities associated with cancer therapies are poorly understood mechanistically, and novel strategies are needed to balance cardiovascular damage with effective cancer treatment.
This perspective emphasizes the growing importance of cardio-oncology and the critical need for novel strategies to mitigate cardiovascular toxicities associated with life-saving cancer therapies.
No takes yet. Share an insight, caveat, or question.
Heightens cardiotoxicity awareness in cancer care; leaves open mechanistic targets for future interventions.
Beyer et al. (2019) conducted a review in Cancer therapy-induced cardiovascular toxicity. Cancer therapies was evaluated. Cancer therapies are associated with acute and chronic cardiovascular toxicities that are poorly understood mechanistically, highlighting the need for novel cardio-oncology research strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: